McClain Value Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
McClain Value Management's PFE Position: Q2 2017 in Review
McClain Value Management sold out of Pfizer (PFE) in Q2 2017, closing a stake of 9,154 shares — an estimated $297K sold.
McClain Value Management first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $25.5M in Q4 2014. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.
- McClain Value Management reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
- McClain Value Management sold 9,154 Pfizer shares in Q2 2017, an estimated $297K.
- McClain Value Management first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
- McClain Value Management's Pfizer position peaked at $25.5M in Q4 2014.
- 2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.
Based on McClain Value Management's 13F filing for Q2 2017, filed 14 Aug 2017.